Klarissa Hardy was awarded $660,000 to further her research on the anti-cancer drug called lapatinib, a drug that causes liver damage in some patients. It is Hardy's goal to identify the genetic factors that contribute to a patient's risk for liver damage when utilizing this and other drugs. Read more here.Read More